| Average Daily Range |
| Avg Daily Range: |
$0.99 | 4.01%
|
| Avg Daily Range (30 D): |
$2.91 | 3.66%
|
| Avg Daily Range (90 D): |
$1.75 | 2.81%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.5M |
| Avg Daily Volume (30 D): |
.87M |
| Avg Daily Volume (90 D): |
.53M |
| Trade Size |
| Avg Trade Size (Sh.): |
98 |
| Avg Trade Size (Sh.) (30 D): |
35 |
| Avg Trade Size (Sh.) (90 D): |
41 |
| Institutional Trades |
| Total Inst.Trades: |
1,241 |
| Avg Inst. Trade: |
$2.35M |
| Avg Inst. Trade (30 D): |
$4.96M |
| Avg Inst. Trade (90 D): |
$3.04M |
| Avg Inst. Trade Volume: |
.04M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.86M |
| Avg Closing Trade (30 D): |
$8.42M |
| Avg Closing Trade (90 D): |
$4.49M |
| Avg Closing Volume: |
42.49K |
|
|
| News |
Oct 17, 2025 @ 3:45 AM
Praxis Precision Medicines, Inc. Announces Pricing...
Source: Praxis Precision Medicines, Inc.
|
Sep 15, 2025 @ 9:42 PM
PRAXIS ALERT: Bragar Eagel & Squire, P.C. is Inves...
Source: Bragar Eagel & Squire, P.C.
|
Aug 29, 2025 @ 12:00 PM
Praxis Precision Medicines to Participate in Upcom...
Source: Marcio Souza (Ceo)
|
Aug 23, 2025 @ 1:32 PM
PRAXIS ALERT: Bragar Eagel & Squire, P.C. is Inves...
Source: Bragar Eagel & Squire, P.C.
|
Aug 17, 2025 @ 2:59 PM
INVESTOR ALERT: Pomerantz Law Firm Investigates Cl...
Source: Pomerantz Llp
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$-12.35
|
$-3.31
|
$-3.29
|
|
Diluted EPS
|
$-12.35
|
$-3.31
|
$-3.29
|
|
Revenue
|
$ 7.77M
|
$ M
|
$ M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -251.01M
|
$ -71.13M
|
$ -69.3M
|
|
Operating Income / Loss
|
$ -271.59M
|
$ -76.07M
|
$ -74.73M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ 12.27M
|
$ -8.15M
|
$ -49.81M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Nov 29, 2023:
1:15
|
|
|
|
